Los Angeles Capital Management
DPLO

Los Angeles Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Los Angeles Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,420
Closed -$257K – 1432
2017
Q3 		$257K Sell
12,420
-3,470
-22% -$58.7K ﹤0.01% 1189
2017
Q2 		$235K Buy
+15,890
New +$265K ﹤0.01% 1128

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Los Angeles Capital Management's DPLO Position: Q4 2017 in Review

Los Angeles Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 12,420 shares — an estimated $257K sold.

Los Angeles Capital Management first reported a position in DPLO in Q2 2017 and held it in 2 quarters. The position peaked at $257K in Q3 2017. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

  • Los Angeles Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
  • Los Angeles Capital Management sold 12,420 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $257K.
  • Los Angeles Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2017 and held it in 2 quarters.
  • Los Angeles Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $257K in Q3 2017.
  • 200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on Los Angeles Capital Management's 13F filing for Q4 2017, filed 5 Feb 2018.